The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3665550)

Published in PLoS One on May 28, 2013

Authors

Lorena Rodríguez-Rubio1, Beatriz Martínez, Ana Rodríguez, David M Donovan, Friedrich Götz, Pilar García

Author Affiliations

1: DairySafe Group, Department of Technology and Biotechnology of Dairy Products, Instituto de Productos Lácteos de Asturias-Consejo Superior de Investigaciones Científicas, Villaviciosa, Asturias, Spain.

Articles cited by this

Staphylococcus aureus infections. N Engl J Med (1998) 36.39

A bacteriolytic agent that detects and kills Bacillus anthracis. Nature (2002) 5.63

Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72

Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol (2005) 2.55

Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Proc Natl Acad Sci U S A (1988) 2.49

Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol (2008) 2.18

The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect (2006) 2.14

Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem (1999) 2.05

MRSA--the tip of the iceberg. Clin Microbiol Infect (2006) 1.81

Bacteriophage endolysins as novel antimicrobials. Future Microbiol (2012) 1.68

Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis (2007) 1.61

Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk. Int J Food Microbiol (2008) 1.36

Endolysins as antimicrobials. Adv Virus Res (2012) 1.33

LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett (2008) 1.30

Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol (2008) 1.26

Molecular aspects and comparative genomics of bacteriophage endolysins. J Virol (2013) 1.25

The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl Environ Microbiol (2006) 1.20

Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs (2011) 1.13

Synergy between the phage endolysin LysH5 and nisin to kill Staphylococcus aureus in pasteurized milk. Int J Food Microbiol (2010) 1.07

LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol (2010) 1.07

Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo. Antimicrob Agents Chemother (2006) 1.03

Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol (2012) 1.02

Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol (2011) 1.01

Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Appl Environ Microbiol (2012) 0.92

Endolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity. J Am Chem Soc (2012) 0.91

Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'. J Biotechnol (2012) 0.84

Articles by these authors

Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol (2005) 2.76

Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol (2005) 2.61

Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe (2010) 2.49

Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol (2006) 2.40

Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun (2010) 2.33

Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2007) 2.14

Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun (2006) 2.13

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). J Clin Oncol (2005) 2.09

Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett (2006) 2.06

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis (2002) 2.05

Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J Biol Chem (2005) 2.00

De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain. Neurosurgery (2016) 1.96

Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog (2007) 1.92

Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke (2004) 1.85

Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol Microbiol (2010) 1.82

Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun (2005) 1.80

Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics (2006) 1.79

Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun (2005) 1.76

Bacteriophage endolysins as novel antimicrobials. Future Microbiol (2012) 1.68

Bacteria-derived peptidoglycans constitute pathogen-associated molecular patterns triggering innate immunity in Arabidopsis. J Biol Chem (2007) 1.68

Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology (2005) 1.68

Arabidopsis lysin-motif proteins LYM1 LYM3 CERK1 mediate bacterial peptidoglycan sensing and immunity to bacterial infection. Proc Natl Acad Sci U S A (2011) 1.65

Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol (2003) 1.61

Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potential. BMC Genomics (2012) 1.57

Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson. Int J Med Microbiol (2004) 1.57

Inhibition of staphylococcal biofilm formation by nitrite. J Bacteriol (2007) 1.51

The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol (2008) 1.51

Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol (2006) 1.50

Biocontrol of psychrotrophic enterotoxigenic Bacillus cereus in a nonfat hard cheese by an enterococcal strain-producing enterocin AS-48. J Food Prot (2004) 1.50

[Cardiac surgery in elderly patients]. Rev Esp Cardiol (2002) 1.49

Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategy. AJNR Am J Neuroradiol (2005) 1.43

The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun (2006) 1.41

Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol (2008) 1.38

Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk. Int J Food Microbiol (2008) 1.36

A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol Microbiol (2007) 1.34

Microevolution of cytochrome bd oxidase in Staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J Bacteriol (2006) 1.33

Endolysins as antimicrobials. Adv Virus Res (2012) 1.33

Suicidal erythrocyte death in sepsis. J Mol Med (Berl) (2006) 1.30

LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett (2008) 1.30

Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int J Med Microbiol (2008) 1.29

Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis (2008) 1.28

Cell envelope stress induced by the bacteriocin Lcn972 is sensed by the Lactococcal two-component system CesSR. Mol Microbiol (2007) 1.28

Real-time PCR designs to estimate nuclear and mitochondrial DNA copy number in forensic and ancient DNA studies. Forensic Sci Int (2004) 1.27

Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol (2010) 1.26

Geolocators reveal migration and pre-breeding behaviour of the critically endangered Balearic Shearwater Puffinus mauretanicus. PLoS One (2012) 1.22

Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain. Gene (2009) 1.22

Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis. FEMS Immunol Med Microbiol (2003) 1.21

Structural basis of cell wall cleavage by a staphylococcal autolysin. PLoS Pathog (2010) 1.20

Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J (2010) 1.19

Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J Immunol (2009) 1.18

Marker removal in staphylococci via Cre recombinase and different lox sites. Appl Environ Microbiol (2007) 1.18

The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model. Microb Pathog (2004) 1.18

Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol (2009) 1.16

Characterization of toxin production of coagulase-negative staphylococci isolated from food and starter cultures. Int J Food Microbiol (2008) 1.15

Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol (2012) 1.15

Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One (2010) 1.14

Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol (2009) 1.13

Development and validation of a prognostic nomogram for terminally ill cancer patients. J Natl Cancer Inst (2011) 1.12

Phage release from biofilm and planktonic Staphylococcus aureus cells. FEMS Microbiol Lett (2005) 1.11

The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbiol Lett (2008) 1.11

A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell Microbiol (2010) 1.11

Advantage of upregulation of succinate dehydrogenase in Staphylococcus aureus biofilms. J Bacteriol (2010) 1.10

Factors affecting tyramine production in Enterococcus durans IPLA 655. Appl Microbiol Biotechnol (2006) 1.08

Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood (2002) 1.07

Synergy between the phage endolysin LysH5 and nisin to kill Staphylococcus aureus in pasteurized milk. Int J Food Microbiol (2010) 1.07

Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohypophyseal system. J Biol Chem (2003) 1.07

Incidence of Staphylococcus aureus and analysis of associated bacterial communities on food industry surfaces. Appl Environ Microbiol (2012) 1.07

Staphylococcal major autolysin (Atl) is involved in excretion of cytoplasmic proteins. J Biol Chem (2010) 1.06

Characterization of the oxygen-responsive NreABC regulon of Staphylococcus aureus. J Bacteriol (2008) 1.05

Role of the twin-arginine translocation pathway in Staphylococcus. J Bacteriol (2009) 1.04

Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. Infect Immun (2004) 1.03

Ligand-binding properties and conformational dynamics of autolysin repeat domains in staphylococcal cell wall recognition. J Bacteriol (2012) 1.03

Murine peripherin gene sequences direct Cre recombinase expression to peripheral neurons in transgenic mice. FEBS Lett (2002) 1.03

Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol (2012) 1.02

The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Eur J Immunol (2005) 1.02

Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol (2006) 1.01

Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol (2011) 1.01

Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One (2012) 1.01

Alternatives to antibiotics: a symposium on the challenges and solutions for animal production. Anim Health Res Rev (2013) 1.01

Functional genomic analysis of two Staphylococcus aureus phages isolated from the dairy environment. Appl Environ Microbiol (2009) 1.00

Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome. Clin Transplant (2003) 0.99

Synthesis of a new chiral pyrrolidine. Molecules (2010) 0.99

Pyruvate formate lyase acts as a formate supplier for metabolic processes during anaerobiosis in Staphylococcus aureus. J Bacteriol (2010) 0.98

Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme. FEMS Microbiol Lett (2013) 0.98

Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2012) 0.96

Staphylococcal NreB: an O(2)-sensing histidine protein kinase with an O(2)-labile iron-sulphur cluster of the FNR type. Mol Microbiol (2004) 0.96